ImExHS Limited (AU:IME) has released an update.
IMEXHS Limited, an innovative provider of cloud-based medical imaging software, reported a strong sales performance in 2023, despite global economic challenges. The company has seen a shift towards USD-denominated revenue, which now accounts for 45% of their total revenue. With robust year-over-year growth, IMEXHS enters 2024 poised for further revenue and earnings increases, thanks to new contracts and expanded services for existing clients.
For further insights into AU:IME stock, check out TipRanks’ Stock Analysis page.
